Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice-Reference-Cited by-同舟云学术

Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice

Published:2011-05 Issue:5 Volume:52 Page:885-896
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Mullick Adam E.,Fu Wuxia,Graham Mark J.,Lee Richard G.,Witchell Donna,Bell Thomas A.,Whipple Charles P.,Crooke Rosanne M.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference37 articles.

1. The cholesterol controversy is over. Why did it take so long?;Steinberg;Circulation.,1989

2. Genetic basis of atherosclerosis: part I: new genes and pathways;Lusis;Circulation.,2004

3. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications;Tabas;Circulation.,2007

4. Lipoproteins and atherogenesis. Current concepts;Steinberg;JAMA.,1990

5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Arterioscler. Thromb. Vasc. Biol.,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs;Communications Biology;2024-04-23

2. Gene transfer and genome editing for familial hypercholesterolemia;Frontiers in Molecular Medicine;2023-04-03

3. Early life exercise training and inhibition of apoLpp mRNA expression to improve age-related arrhythmias and prolong the average lifespan in Drosophila melanogaster;Aging;2022-12-05

4. Delivery of Oligonucleotides: Efficiency with Lipid Conjugation and Clinical Outcome;Pharmaceutics;2022-02-01

5. Mipomersen in Familial Hypercholesterolemia: An Update on Health-Related Quality of Life and Patient-Reported Outcomes;Vascular Health and Risk Management;2022-02